Citigroup’s CAS Medical Systems, Inc. CASM Stock Holding History

Citigroup’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,000	Closed	-$5K	–	7963
2019 Q1	$5K	Hold	2,000	–	–	﹤0.01%	7439
2018 Q4	$3K	Hold	2,000	–	–	﹤0.01%	7481
2018 Q3	$5K	Buy	+2,000	New	+$4.26K	﹤0.01%	7511

Citigroup's CASM Position: Q2 2019 in Review

Citigroup sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 2,000 shares — an estimated $5K sold.

Citigroup first reported a position in CASM in Q3 2018 and held it in 3 quarters. The position peaked at $5K in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.

Citigroup reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
Citigroup sold 2,000 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $5K.
Citigroup first reported a position in CAS Medical Systems, Inc. in Q3 2018 and held it in 3 quarters.
Citigroup's CAS Medical Systems, Inc. position peaked at $5K in Q1 2019.
0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.